Why the study?
Does spectral analysis of heart rate variability accurately estimate cardiac sympathetic activity in normal subjects and patients with heart failure?
Does spectral analysis of heart rate variability accurately estimate cardiac sympathetic activity in normal subjects and patients with heart failure?
Spectral analysis of heart rate variability is not a reliable surrogate for direct measures of cardiac sympathetic activation in individual heart failure patients.
Answers are grounded in this paper and cite their sources.
Spectral HRV analysis should not estimate cardiac sympathetic activity in individual HF patients; challenges consensus on its surrogate validity and leaves open direct-measure validation.
Spectral analysis of heart rate variability has gained popularity as a simple, non-invasive tool for assessing autonomic function in both normal subjects and in patients in a variety of clinical settings. However, the use of this method as a means of estimating the magnitude of cardiac sympathetic activation in individual patients with heart failure has proved disappointing, with a lack of concordance with more direct measures of sympathetic outflow. This review will describe the rationale involved in using sympathetic indices obtained from spectral analysis of heart rate variability to assess cardiac sympathetic outflow in normal subjects and patients with heart failure. The specific limitations and technological concerns that dictate how it may most effectively be used in this patient population will be discussed.
No takes yet. Share an insight, caveat, or question.
Catherine F. Notarius (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: